1. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. Washington, DC: US Public Health Service. 2014 May 20.
2. Centers for Disease Control and Prevention [Internet]. HIV/AIDS; 2017 Aug 31 [cited 2019 Aug 26]. Available from: https://www.cdc.gov/hiv/risk/prep/index.html.
3. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010 Dec 30;363(27):2587–99. doi: 10.1056/NEJMoa1011205 21091279
4. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine. 2012 Aug 2;367(5):399–410. doi: 10.1056/NEJMoa1108524 22784037
5. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013 Jun 15;381(9883):2083–90.
6. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet. 2016 Jan 2;387(10013):53–60.
7. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine. 2015 Dec 3;373(23):2237–46. doi: 10.1056/NEJMoa1506273 26624850
8. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016. Vol. 28. 2017.
9. Centers for Disease Control and Prevention. HIV surveillance report, 2017; vol. 29. 2018.
10. Mera R, McCallister S, Palmer B, Mayer G, Magnuson D, Rawlings MK. FTC/TDF (Truvada) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: 2012–2015. Foster City, CA, USA. 2016 Jul 18.
11. Highleyman L. PrEP use exceeds 79,000 in US pharmacy survey, but some groups lagging behind [Internet]; 2016 Jul 19 [cited 2017 Nov 23]; Available from: http://www.aidsmap.com/PrEP-use-exceeds-79000-in-US-pharmacy-survey-but-some-groups-lagging-behind/page/3072084
12. Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, National HIV Behavioral Surveillance Study Group, Wortley P, et al. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men—20 US cities, 2014. Clinical Infectious Diseases. 2016 Jun 9;63(5):672–7. doi: 10.1093/cid/ciw367 27282710
13. Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: the motivational PrEP cascade. Journal of acquired immune deficiency syndromes (1999). 2017 Mar 1;74(3):285.
14. Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS patient care and STDs. 2015 Feb 1;29(2):102–10. doi: 10.1089/apc.2014.0142 25513954
15. Sharma M, Wilton J, Senn H, Fowler S, Tan DH. Preparing for PrEP: perceptions and readiness of Canadian physicians for the implementation of HIV pre-exposure prophylaxis. PLoS One. 2014 Aug 18;9(8):e105283. doi: 10.1371/journal.pone.0105283 25133648
16. Seidman D, Carlson K, Weber S, Witt J, Kelly PJ. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey. Contraception. 2016 May 1;93(5):463–9. doi: 10.1016/j.contraception.2015.12.018 26772906
17. Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH. Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS care. 2014 Jun 3;26(6):684–93. doi: 10.1080/09540121.2013.845289 24116985
18. Senn H, Wilton J, Sharma M, Fowler S, Tan DH. Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. AIDS research and human retroviruses. 2013 Sep 1;29(9):1183–9. doi: 10.1089/AID.2013.0090 23731254
19. Desai M, Gafos M, Dolling D, McCormack S, Nardone A, PROUD study. Healthcare providers' knowledge of, attitudes to and practice of pre‐exposure prophylaxis for HIV infection. HIV medicine. 2016 Feb;17(2):133–42. doi: 10.1111/hiv.12285 26172217
20. Nnumolu C, Brady KA, Miller M, Nassau T. Philadelphia Department of Public Health, AIDS Activities Coordinating Office Surveillance Report, 2016. Philadelphia, PA: City of Philadelphia. 2017.
21. Tariq S, Woodman J. Using mixed methods in health research. JRSM short reports. 2013 May 7;4(6):2042533313479197. doi: 10.1177/2042533313479197 23885291
22. Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC infectious diseases. 2013 Dec;13(1):217.
23. Ajzen I. The theory of planned behavior. Organizational behavior and human decision processes. 1991 Dec 1;50(2):179–211.
24. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. American journal of health promotion. 1996 Nov;11(2):87–98. doi: 10.4278/0890-1171-11.2.87 10163601
25. Blue CL. The predictive capacity of the theory of reasoned action and the theory of planned behavior in exercise research: An integrated literature review. Research in nursing & health. 1995 Apr;18(2):105–21.
26. Roncancio AM, Ward KK, Sanchez IA, Cano MA, Byrd TL, Vernon SW, et al. Using the theory of planned behavior to understand cervical cancer screening among Latinas. Health Education & Behavior. 2015 Oct;42(5):621–6.
27. Riebl SK, Estabrooks PA, Dunsmore JC, Savla J, Frisard MI, Dietrich AM, et al. A systematic literature review and meta-analysis: The Theory of Planned Behavior's application to understand and predict nutrition-related behaviors in youth. Eating behaviors. 2015 Aug 1;18:160–78. doi: 10.1016/j.eatbeh.2015.05.016 26112228
28. Lapkin S, Levett-Jones T, Gilligan C. Using the Theory of Planned Behaviour to examine health professional students' behavioural intentions in relation to medication safety and collaborative practice. Nurse education today. 2015 Aug 1;35(8):935–40. doi: 10.1016/j.nedt.2015.03.018 25935666
29. Tyson M, Covey J, Rosenthal HE. Theory of planned behavior interventions for reducing heterosexual risk behaviors: A meta-analysis. Health Psychology. 2014 Dec;33(12):1454. doi: 10.1037/hea0000047 24707843
30. Starks H, Brown Trinidad S. Choose your method: A comparison of phenomenology, discourse analysis, and grounded theory. Qualitative health research. 2007 Dec;17(10):1372–80. doi: 10.1177/1049732307307031 18000076
31. Eaton LA, Kalichman SC. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Current hiv/aids Reports. 2007 Nov 1;4(4):165–72. doi: 10.1007/s11904-007-0024-7 18366947
32. Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. Morbidity and Mortality Weekly Report. 2015 Nov 27;64(46):1291–5. doi: 10.15585/mmwr.mm6446a4 26606148
33. Smith DK, Mendoza MC, Stryker JE, Rose CE. PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS One. 2016 Jun 3;11(6):e0156592. doi: 10.1371/journal.pone.0156592 27258374
34. Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Hawkins LA, et al. “Support Your Client at the Space That They're in”: HIV pre-exposure prophylaxis (PrEP) prescribers' perspectives on PrEP-related risk compensation. AIDS patient care and STDs. 2017 Apr 1;31(4):196–204. doi: 10.1089/apc.2017.0002 28414261
35. Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS and Behavior. 2014 Sep 1;18(9):1712–21. doi: 10.1007/s10461-014-0839-3 24965676
36. Calabrese SK, Earnshaw VA, Krakower DS, Underhill K, Vincent W, Magnus M, et al. A closer look at racism and heterosexism in medical students’ clinical decision-making related to HIV pre-exposure prophylaxis (PrEP): implications for PrEP education. AIDS and Behavior. 2018 Apr 1;22(4):1122–38. doi: 10.1007/s10461-017-1979-z 29151200
37. Galang RR, Mendoza MC, Smith DK. HIV Preexposure Prophylaxis among US Adults: Awareness of and Willingness to Recommend or Take–HealthStyles Surveys, 2009–2014. of. 2017;8:2009–14.
38. Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Quality & quantity. 2018 Jul 1;52(4):1893–907.